GlassScriptPhysician profile
Paul S Collins
NPI 1962499715
$5,057.72
in general payments reported to CMS, 2019-2025
35 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,116 · 2020: $857 · 2021: $583 · 2022: $202 · 2023: $647 · 2024: $444 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Travel and Lodging: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.65 |
| Travel and Lodging | $138.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,070.40 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Stent Graft |
| Cook Medical LLC | $840.91 | 2019-2022 | |
| Medtronic Vascular, INC. | $808.50 | 2019-2020 | |
| Silk Road Medical, INC. | $447.94 | 2019 | |
| Endologix LLC | $321.13 | 2019 | |
| Smith+Nephew, INC. | $283.21 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Pico |
| Cvrx, INC. | $149.91 | 2023 | Barostim Neo System |
| Boston Scientific Corporation | $140.74 | 2020-2023 | Varithena Administration Pack |
| Medtronic, INC. | $99.57 | 2021-2022 | |
| Ethicon US, LLC | $94.12 | 2019-2023 | Prolene, Vistaseal |
| Medela LLC | $91.24 | 2020 | |
| Bolton Medical INC | $76.00 | 2021 | |
| Endogastric Solutions, INC | $61.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.62 | 2019-2024 | Xarelto |
| Kci USA, INC. | $49.37 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $41.52 | 2020 | |
| Acera Surgical, INC. | $37.39 | 2024 | Restrata Wound Matrix |
| Bard Peripheral Vascular, INC. | $36.38 | 2019-2020 | |
| Kerecis Limited | $33.18 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Lemaitre Vascular, INC. | $32.07 | 2019 | |
| Tei Biosciences INC | $24.77 | 2019 | |
| Covidien LP | $23.62 | 2019 | |
| Philips North America LLC | $22.10 | 2020 | |
| Penumbra, INC. | $21.37 | 2024 | Penumbra System |
| Venclose INC. | $21.16 | 2019 | |
| Ekos Corporation | $20.99 | 2019 | |
| Acell, INC. | $20.53 | 2020 | |
| Cardiovascular Systems INC. | $20.36 | 2021 | |
| Csl Behring | $19.91 | 2019 | |
| Biocompatibles, INC. | $19.66 | 2019 | |
| Shockwave Medical, INC | $16.60 | 2022 | |
| Artivion, INC. | $15.33 | 2019 | |
| Cashflow Solutions, LLC | $13.68 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Endo Pharmaceuticals INC. | $12.90 | 2019 | |
| Angiodynamics, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.